378 related articles for article (PubMed ID: 19488961)
21. The interaction between piperacillin/tazobactam and assays for Aspergillus galactomannan and 1,3-beta-D-glucan in patients without risk factors for invasive fungal infections.
Metan G; Ağkuş C; Buldu H; Koç AN
Infection; 2010 Jun; 38(3):217-21. PubMed ID: 20237947
[TBL] [Abstract][Full Text] [Related]
22. [The value of serum galactomannan antigen for detection of invasive aspergillosis in hematological patients].
Xie LP; Liu T; Meng WT; Zhou J
Zhonghua Nei Ke Za Zhi; 2006 Dec; 45(12):992-5. PubMed ID: 17326997
[TBL] [Abstract][Full Text] [Related]
23. Comparative evaluation of pan-fungal real-time PCR, galactomannan and (1-3)-β-D-glucan assay for invasive fungal infection in paediatric cancer patients.
Gupta P; Ahmad A; Khare V; Kumar A; Banerjee G; Verma N; Singh M
Mycoses; 2017 Apr; 60(4):234-240. PubMed ID: 27862370
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of glucan and galactomannan tests with real-time PCR for diagnosis of invasive aspergillosis in a neutropenic rat model].
Aydoğan S; Kuştimur S; Kalkancı A
Mikrobiyol Bul; 2010 Jul; 44(3):441-52. PubMed ID: 21063994
[TBL] [Abstract][Full Text] [Related]
25. What should be the optimal cut-off of serum 1,3-β-D-glucan for the detection of invasive pulmonary aspergillosis in patients with haematological malignancies?
Metan G; Koç AN; Atalay A; Kaynar LG; Ozturk A; Alp E; Eser B
Scand J Infect Dis; 2012 May; 44(5):330-6. PubMed ID: 22188426
[TBL] [Abstract][Full Text] [Related]
26. Comparison of PCR-ELISA and galactomannan detection for the diagnosis of invasive aspergillosis.
Scotter JM; Campbell P; Anderson TP; Murdoch DR; Chambers ST; Patton WN
Pathology; 2005 Jun; 37(3):246-53. PubMed ID: 16175901
[TBL] [Abstract][Full Text] [Related]
27. Quantification of 1,3-β-d-glucan by Wako β-glucan assay for rapid exclusion of invasive fungal infections in critical patients: A diagnostic test accuracy study.
Cento V; Alteri C; Mancini V; Gatti M; Lepera V; Mazza E; Moioli MC; Merli M; Colombo J; Orcese CA; Bielli A; Torri S; Gasparini LE; Vismara C; De Gasperi A; Brioschi P; Puoti M; Cairoli R; Lombardi G; Perno CF
Mycoses; 2020 Dec; 63(12):1299-1310. PubMed ID: 32810888
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of biomarkers: Galactomannan and 1,3-beta-D-glucan assay for the diagnosis of invasive fungal infections in immunocompromised patients from a tertiary care centre.
Singh S; Kaur H; Choudhary H; Sethi S; Malhotra P; Gupta KL; Rudramurthy SM; Chakrabarti A
Indian J Med Microbiol; 2018; 36(4):557-563. PubMed ID: 30880706
[TBL] [Abstract][Full Text] [Related]
29. Performance Characteristics of Galactomannan and β-d-Glucan in High-Risk Liver Transplant Recipients.
Singh N; Winston DJ; Limaye AP; Pelletier S; Safdar N; Morris MI; Meneses K; Busuttil RW; Wagener MM; Wheat LJ
Transplantation; 2015 Dec; 99(12):2543-50. PubMed ID: 26050015
[TBL] [Abstract][Full Text] [Related]
30. Galactomannan does not precede major signs on a pulmonary computerized tomographic scan suggestive of invasive aspergillosis in patients with hematological malignancies.
Weisser M; Rausch C; Droll A; Simcock M; Sendi P; Steffen I; Buitrago C; Sonnet S; Gratwohl A; Passweg J; Fluckiger U
Clin Infect Dis; 2005 Oct; 41(8):1143-9. PubMed ID: 16163633
[TBL] [Abstract][Full Text] [Related]
31. [The performance of (1, 3)-beta-D-glucan and Aspergillus galactomannan measurement for early diagnosis of invasive aspergillosis in patients with hematological diseases].
Horiguchi Y
Kansenshogaku Zasshi; 2004 Jul; 78(7):566-73. PubMed ID: 15359888
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of pan-fungal PCR assay and Aspergillus antigen detection in the diagnosis of invasive fungal infections in high risk paediatric cancer patients.
El-Mahallawy HA; Shaker HH; Ali Helmy H; Mostafa T; Razak Abo-Sedah A
Med Mycol; 2006 Dec; 44(8):733-9. PubMed ID: 17127630
[TBL] [Abstract][Full Text] [Related]
33. (1, 3)-β-D-glucan assay for diagnosing invasive fungal infections in critically ill patients with hematological malignancies.
Azoulay E; Guigue N; Darmon M; Mokart D; Lemiale V; Kouatchet A; Mayaux J; Vincent F; Nyunga M; Bruneel F; Rabbat A; Bretagne S; Lebert C; Meert AP; Benoit D; Pene F
Oncotarget; 2016 Apr; 7(16):21484-95. PubMed ID: 26910891
[TBL] [Abstract][Full Text] [Related]
34. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.
Yamaguchi M; Kurokawa T; Ishiyama K; Aoki G; Ueda M; Matano S; Takami A; Yamazaki H; Sawazaki A; Yamauchi H; Yoshida T; Nakao S
Ann Hematol; 2011 Oct; 90(10):1209-17. PubMed ID: 21695388
[TBL] [Abstract][Full Text] [Related]
35. How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors.
Hammarström H; Kondori N; Friman V; Wennerås C
Eur J Clin Microbiol Infect Dis; 2015 May; 34(5):917-25. PubMed ID: 25573536
[TBL] [Abstract][Full Text] [Related]
36. Role of (1-->3)-beta-D-glucan in the diagnosis of invasive aspergillosis.
Marty FM; Koo S
Med Mycol; 2009; 47 Suppl 1():S233-40. PubMed ID: 18720216
[TBL] [Abstract][Full Text] [Related]
37. Clinical utility of fungal screening assays in adults with severe burns.
Blyth DM; Chung KK; Cancio LC; King BT; Murray CK
Burns; 2013 May; 39(3):413-9. PubMed ID: 22999208
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Serum Galactomannan and 1,3-Beta-D-Glucan Determination for Early Detection of Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hematological Malignancies and Septic Shock.
Lahmer T; Rasch S; Schnappauf C; Beitz A; Schmid RM; Huber W
Mycopathologia; 2016 Aug; 181(7-8):505-11. PubMed ID: 27142781
[TBL] [Abstract][Full Text] [Related]
39. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of Mass Spectrometry-Based Detection of Panfungal Serum Disaccharide for Diagnosis of Invasive Fungal Infections: Results from a Collaborative Study Involving Six European Clinical Centers.
Cornu M; Sendid B; Mery A; François N; Mikulska M; Letscher-Bru V; De Carolis E; Damonti L; Titecat M; Bochud PY; Alanio A; Sanguinetti M; Viscoli C; Herbrecht R; Guerardel Y; Poulain D
J Clin Microbiol; 2019 May; 57(5):. PubMed ID: 30787140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]